Jacobson et al. administered 3 doses of the tetravalent HPV vaccine to 37 previously unvaccinated females aged 9–26 years with IBD, who were prescribed maintenance immunosuppressive therapy for at least 30 days prior to enrollment with any immunomodulator or a TNF-α inhibitor [112]. This evidence concerns the gene TNF and inflammatory bowel disease.